Australia markets close in 28 minutes

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
8.42-0.24 (-2.77%)
At close: 04:00PM EDT
8.42 0.00 (0.00%)
After hours: 06:23PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.4-0.44-1.52-0.58
Low estimate-0.58-0.53-1.82-2.06
High estimate-0.31-0.34-1.321.27
Year ago EPS-0.58-0.49-1.83-1.52
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3345
Avg. EstimateN/AN/AN/A54.93M
Low estimateN/AN/AN/A18.38M
High estimateN/AN/AN/A141.3M
Year ago salesN/A570k81kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.48-0.53-0.54-0.52
Actual EPS-0.58-0.49-0.34-0.31
Difference-0.10.040.20.21
Surprise %-20.80%7.50%37.00%40.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.4-0.44-1.52-0.58
7 days ago-0.4-0.44-1.52-0.59
30 days ago-0.55-0.54-1.92-0.11
60 days ago-0.63-0.6-1.86-0.23
90 days ago-0.63-0.6-1.89-0.23
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 days2242
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATNMIndustrySector(s)S&P 500
Current qtr.31.00%N/AN/AN/A
Next qtr.10.20%N/AN/AN/A
Current year16.90%N/AN/AN/A
Next year61.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A